Clearblue Menopause Stage Indicator Review: Is It Still Worth Buying After App Support Ended?

Your periods have changed. Sleep has become unpredictable. You’d like something more definite than another evening of searching symptoms on your phone, and a test from a familiar brand sounds reassuring.

Before buying this particular box, there is a practical change to know about. Clearblue’s US product page says the Menopause Stage Indicator is being discontinued and its Menopause Stage – Clearblue me app is no longer supported starting September 1, 2026. That date has passed as of this October 10, 2026 review. 1

For a new purchase intended to deliver the advertised app-based menopause stage and report, this makes it a poor choice unless Clearblue can confirm what still works for you. Leftover stock and an old positive review don’t establish current support.

Has Clearblue discontinued the menopause test?

Yes. The product page carries the discontinuation notice, and the developer’s US App Store description repeats it. The app listing also retains older descriptions of stage results, tracking and reports. Read those features in the context of the support notice, rather than as a fresh promise of an ongoing service. 2

The announcement doesn’t explain exactly what happens to every previously installed app or account. It doesn’t tell us that every screen is disabled, nor does it promise continued account creation, activation or report access. Those are questions for Clearblue if you’re considering a purchase or trying to recover an existing report.

The brand’s product page still contains older buying links and setup instructions beneath the notice. Their presence doesn’t resolve the support issue. Check the notice first, before spending time choosing a retailer or comparing discounts. 1

Can you use the sticks without the app?

You can distinguish the stick’s intended measurement from the kit’s advertised stage calculation. Clearblue’s FAQ says the app combines FSH results, age and cycle history; the sticks alone cannot indicate your likely menopause stage. 3

The package insert makes the same distinction: without the app, you get FSH results only. It also says not to use sticks after their expiration date or if the foil wrapper is damaged. An unopened box isn’t enough; the date and storage condition still matter. 5

That limits the case for buying remaining stock. If your main reason for choosing this kit was a personalized stage report, five sticks by themselves aren’t the same purchase. Don’t pay for an app-dependent benefit you haven’t confirmed you can receive.

If you already own the kit, retain the packaging and ask Clearblue about your exact situation. Include whether you have an existing account, whether the activation code has been used and whether a report was previously generated. There’s no need to invent a workaround or reinterpret the lines as a homemade stage algorithm.

What does a positive Clearblue menopause test mean?

For these sticks, the manufacturer’s FAQ says a positive result means urinary FSH is at least 25 mIU/mL that day. A negative result means it is below that threshold. It isn’t a complete measurement of estrogen, progesterone or every hormone associated with symptoms. 3

FSH is follicle-stimulating hormone. FDA explains that it rises temporarily during the menstrual cycle and can become elevated as ovarian function changes near menopause. A home urine test detects elevated FSH; that finding alone doesn’t establish menopause or perimenopause. 6

The helpful distinction is between a hormone result and the explanation you’ve been looking for. A line on a stick can be information to discuss. It doesn’t identify the cause of every symptom, decide whether treatment is appropriate or predict exactly when your last period will happen.

Is the “over 99% accurate” claim about diagnosing menopause?

No. Clearblue’s professional page describes greater than 99% accuracy in laboratory testing with positive and negative FSH urine samples, using a positive threshold of at least 25 mIU/mL. That is a claim about the sticks’ hormone detection under those conditions. It isn’t a claim that the app correctly diagnoses every user’s menopause stage more than 99% of the time. 4

The manufacturer’s science explanation says the stage calculation used three inputs: age, cycle history and FSH test results. Its published explanation describes the approach and its relationship to reproductive-aging criteria; it doesn’t turn the laboratory stick figure into a separate, independently demonstrated stage-diagnosis rate. 9

The original STRAW+10 consensus treats menstrual bleeding patterns as central to staging and biomarkers as supportive, rather than required for diagnosis. That consensus isn’t a validation trial of this particular consumer app. A product referencing established clinical criteria still needs its own evidence for any specific performance claim. 8

These distinctions help you judge the claim fairly. The test can be designed to detect a hormone accurately while the clinical question remains more complicated than a positive or negative line.

Why were there five tests instead of one?

The kit was designed around five first-morning urine tests on alternate days, followed by the app’s interpretation. The manufacturer says repeated testing helps account for day-to-day FSH variability. It wasn’t designed as one stick giving an instant answer about your menopause stage. 4

That makes the app’s status especially relevant. The original purchase bundled a multi-day testing routine with a calculation using your personal history. Losing support for that calculation affects the reason many people would choose the kit in the first place.

For anyone reading an old result, the package instructions call for waiting five full minutes and reading within eight minutes. A missing control line means the test hasn’t worked; changes after the reading window should be disregarded. A photograph taken hours later isn’t a reliable substitute for the result read on time. 5

Can a negative result rule out perimenopause?

No. FDA cautions that a negative home FSH result doesn’t exclude perimenopause or menopause when you have symptoms. Discuss the symptoms and result with your clinician rather than using the negative line to close the conversation. 6

This matters if you’ve been hoping for a test that will make your experience easier to explain. Your sleep disruption or changing periods don’t become unimportant because the result was below a cutoff on one morning. The next appointment can still focus on what changed, how often it happens and what it interferes with.

Likewise, a positive result doesn’t oblige you to start a supplement, request a particular hormone prescription or label every new symptom menopausal. Bring it as one piece of information alongside the rest of your history.

Does it work with a hormonal IUD, birth control or HRT?

The manufacturer’s restrictions are extensive. Its professional information says the kit isn’t suitable during pregnancy or breastfeeding; with hormonal contraception, including hormonal IUDs; with hormone replacement therapy or medicines affecting FSH; with PCOS; or after procedures affecting the cycle, including hysterectomy, removal of both ovaries or endometrial ablation. 4

Those exclusions aren’t small print to work around. If you chose a hormonal IUD specifically because periods were heavy, a kit that relies on your natural cycle history may not be an appropriate purchase.

Don’t stop prescribed treatment or remove contraception to make a consumer test usable. Ask your clinician how your current medication or surgical history affects assessment. The right evaluation for someone without periods may differ from the right evaluation for someone with changing natural cycles.

Do you need a menopause test before seeing a doctor?

Usually, the useful first step is a conversation about your symptoms and history, rather than buying evidence that you’re allowed to have that conversation.

The UK NICE guideline, updated in April 2026, says otherwise healthy people aged 45 or older with appropriate symptoms can be identified as perimenopausal or menopausal without laboratory testing. For menopause, its no-test criteria include at least 12 months without a period when not using hormonal contraception. That is guidance for clinical assessment, not an invitation to ignore other possible causes. 7

NICE considers clinician-ordered serum FSH in certain younger people, including ages 40–45 with symptoms and cycle changes, or under 40 when menopause is suspected. That is a blood-test decision within an assessment. It doesn’t establish that this discontinued home urine kit is the right alternative. 7

Age, medical history and local clinical practice matter. If the changes are happening earlier than expected, or you’re unsure whether pregnancy or another condition is possible, tell your clinician directly. Repeated consumer tests aren’t a substitute for that evaluation.

Can the result tell you to stop birth control?

No. FDA says not to stop contraception based on a home menopause test and not to use these tests to determine whether you can become pregnant. FSH may vary while ovulation and pregnancy remain possible. A menopause-stage label isn’t a contraceptive plan. 6

Ask your clinician when and how contraception can safely change for your circumstances. That discussion may include your age, method, cycle history and medicines. It deserves more information than five urine sticks can supply.

What if you already have a report or a partly used box?

Clearblue’s notice asks users to use remaining sticks and download their personalized report before expiry. Because the support date has now passed, contact the brand if access is uncertain; the notice doesn’t promise that downloading or completing a new series will remain available indefinitely. 1

If you already downloaded a report, keep the dated copy for your appointment. Treat its stage wording as the product’s indication at the time, with your clinician responsible for interpreting it alongside your history.

For a partly completed series, keep any results you recorded within the proper reading window, along with the dates. Don’t buy more boxes solely to finish an app process without first confirming that the process is still available. Ask the seller about its return conditions for the actual purchase; don’t assume discontinuation automatically guarantees a refund for opened stock.

What is worth tracking instead?

A simple record can make the appointment more concrete: period start dates and flow changes, nights disturbed by sweating, sleep problems, vaginal discomfort, medicine changes and which symptoms interrupt normal activities. You can use a notebook or a private file; a branded app isn’t required to describe what’s happening.

If bleeding is heavy, lasts longer than usual, occurs between periods or after sex, bring that up. ACOG advises evaluation of abnormal bleeding and any bleeding after menopause. Don’t use a home-test stage result to dismiss a bleeding change. 10

The buying decision for Clearblue Menopause Stage Indicator is now dominated by a practical limitation: its advertised experience depended on an app whose support has ended. Even when that experience was supported, elevated FSH was information to interpret rather than a definitive diagnosis or treatment plan.

For help putting the changes into words, My Body Changed. Now What? covers the wider menopause and hormone picture. It gives you a place to start organizing your questions, without needing a test result before asking for help.